Valproate risk form-Surveying 215 clinicians involving 4775 encounters.

Heather Angus-Leppan Melika M MoghimHannah CockLucy KintonMarie Synnott WellsRichard Laugharne

Published in: Acta neurologica Scandinavica (2020)

33%-43% of clinicians reported seizure control deterioration in women changed to alternatives to valproate. Informed consent requires women considering a change are given this information. Systematic capture of data automated through online RAFs and linked to patient outcomes is needed. There remains little data on valproate given for indications other than epilepsy.

Keyphrases

polycystic ovary syndrome
electronic health record
palliative care
pregnancy outcomes
big data
health information
breast cancer risk
machine learning
cervical cancer screening
deep learning
pregnant women
metabolic syndrome